BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34453124)

  • 21. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
    Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
    Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
    Juan J; Muraguchi T; Iezza G; Sears RC; McMahon M
    Genes Dev; 2014 Mar; 28(6):561-75. PubMed ID: 24589553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical Examination is Highly Sensitive and Specific for Detection of the V600E BRAF Mutation in Colorectal Serrated Lesions.
    Yamada N; Eizuka M; Sugimoto R; Tanaka Y; Yanagawa N; Yamano H; Suzuki H; Matsumoto T; Sugai T
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):446-453. PubMed ID: 33306619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRAF mutation as a potential marker to identify the proximal colon serrated polyps with malignant potential.
    Fu X; Zhang X
    Int J Clin Exp Pathol; 2014; 7(11):7319-22. PubMed ID: 25550768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
    Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
    Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis.
    Tsumuraya H; Okayama H; Katagata M; Matsuishi A; Fukai S; Ito M; Sakamoto W; Saito M; Momma T; Nakajima S; Mimura K; Kono K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas.
    Travaglino A; D'Armiento FP; Cassese G; Campanino MR; Borrelli G; Pignatiello S; Luglio G; Maione F; De Palma GD; D'Armiento M
    Histopathology; 2019 Aug; 75(2):160-173. PubMed ID: 30815911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
    Panarelli NC; Vaughn CP; Samowitz WS; Yantiss RK
    Am J Surg Pathol; 2015 Mar; 39(3):313-7. PubMed ID: 25602793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
    Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
    J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.
    Bond CE; Nancarrow DJ; Wockner LF; Wallace L; Montgomery GW; Leggett BA; Whitehall VL
    PLoS One; 2014; 9(3):e91739. PubMed ID: 24651849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4-LEF1 Binding.
    Lanauze CB; Sehgal P; Hayer K; Torres-Diz M; Pippin JA; Grant SFA; Thomas-Tikhonenko A
    Mol Cancer Res; 2021 May; 19(5):823-833. PubMed ID: 33608451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.